Showing results (81-90 of 177) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myelomaMaximilian Merz, Judith Ritsch, Christina Kunz, et al.Biomedicines|August 29, 2024
Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell PretreatmentAnja Grahnert, Sabine Seiffert, Kerstin Wenk, et al.Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.Journal of Geriatric Oncology|November 26, 2022
Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee CommitteeNina Rosa Neuendorff, Nico Gagelmann, Surbhi Singhal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2024
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple MyelomaNico Gagelmann, Danai Dima, Maximilian Merz, et al.Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.Oncotarget|October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trialJonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.NPJ Digital Medicine|April 30, 2025
Predicting progression events in multiple myeloma from routine blood workMaximilian Ferle, Nora Grieb, Markus Kreuz, et al.Bone Marrow Transplantation|November 27, 2025
Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosisJohanna Richter, Nico Gagelmann, Felix Fischbach, et al.Med (New York, N.Y.)|March 30, 2024
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosisFelix Fischbach, Johanna Richter, Lena Kristina Pfeffer, et al.Pageof 18